FDA-EMA Endpoint Tips & Risk-Based Monitoring for Flu, Cancer, MCI
Authoritative guidance on aligning FDA and EMA endpoints across influenza, breast cancer and acute stroke, plus practical risk-based monitoring and audit readiness strategies for MCI with a patient-first focus.
Robert Maxwell
Oct 14, 2025
influenza vaccine trials
breast cancer protocols
Acute stroke endpoints
MCI drug monitoring
